Graf Akcie TNDM (Tandem Diabetes Care Inc). Diskuze k akciím TNDM. Aktuální informace TNDM.

Základní informace o společnosti Tandem Diabetes Care Inc (Akcie TNDM)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 7.85B
Hodnota podniku (EV) 7.52B
Tržby 604.844M
EBITDA 33.189M
Zisk 6.556M
Růst v tržbách Q/Q 57.58 %
Růst v tržbách Y/Y 47.44 %
P/E (Cena vůči ziskům) 1,044.58
Forward P/E 2.26
EV/Sales 12.43
EV/EBITDA 226.54
EV/EBIT 391.16
PEG N/A
Price/Sales 12.98
P/FCF 110.30
Price/Book 21.43
Účetní hodnota na akcii 5.85
Hotovost na akcii 7.74
FCF vůči ceně 0.91 %
Počet zaměstnanců 1,500
Tržba na zaměstnance 403.229k
Profit margin -6.89 %
Operating margin 3.28 %
Gross margin 52.23 %
EBIT margin 3.18 %
EBITDA margin 5.49 %
EPS - Zisk na akcii 0.12
EPS - Kvartální růst -113.33 %
EPS - Očekávaný růst příští rok -140.00 %
Return on assets 0.89 %
Return on equity 1.94 %
ROIC -4.50 %
ROCE 2.80 %
Dluhy/Equity 0.96
Čistý dluh/EBITDA -27.65
Current ratio 6.42
Quick Ratio 5.81
Volatilita 3.19
Beta 0.57
RSI 52.95
Cílová cena analytiků 129
Známka akcie (dle analytiků) 1.67
Insider ownership 1.23 %
Institutional ownership 96.79 %
Počet akcií 63.029M
Procento shortovaných akcií 6.74 %
Short ratio 5.22 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie TNDM

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$498.83$362.305$183.866$107.601$84.248$72.85
Cost Of Goods Sold$238.31$168.093$94.044$63.507$60.656$46.27
Gross Profit$260.52$194.212$89.822$44.094$23.592$26.58
Research And Development Expenses$63.574$45.199$29.227$20.661$18.809$16.963
SG&A Expenses$204.903$165.735$105.226$86.377$82.834$78.621
Other Operating Income Or Expenses------
Operating Expenses$506.787$379.027$228.497$170.545$162.299$141.854
Operating Income$-7.957$-16.722$-44.631$-62.944$-78.051$-69.004
Total Non-Operating Income/Expense$-28.325$-7.882$-77.929$-10.081$-5.411$-3.404
Pre-Tax Income$-36.282$-24.604$-122.56$-73.025$-83.462$-72.408
Income Taxes$-1.9$0.149$0.051$0.008$-0.015$0.01
Income After Taxes$-34.382$-24.753$-122.611$-73.033$-83.447$-72.418
Other Income------
Income From Continuous Operations$-34.382$-24.753$-122.611$-73.033$-83.447$-72.418
Income From Discontinued Operations------
Net Income$-34.382$-24.753$-122.611$-73.033$-83.447$-72.418
EBITDA$11.294$-11.215$-36.55$-56.094$-72.647$-64.171
EBIT$-7.957$-16.722$-44.631$-62.944$-78.051$-69.004
Basic Shares Outstanding615948633
Shares Outstanding615948633
Basic EPS$-0.56$-0.42$-2.55$-12.87$-27.30$-25.04
EPS - Earnings Per Share$-0.56$-0.42$-2.55$-12.87$-27.30$-25.04
# 2020 2019 2018 2017 2016 2015
Current Ratio6.1362.77822.83441.77792.92584.0341
Long-term Debt / Capital0.3566--1.6151.08120.3157
Debt/Equity Ratio0.5541---2.6259-13.32210.4613
Gross Margin52.226253.604648.851940.979228.00336.4859
Operating Margin-1.5951-4.6155-24.2737-58.4976-92.6443-94.7207
EBIT Margin-1.5951-4.6155-24.2737-58.4976-92.6443-94.7207
EBITDA Margin2.2641-3.0955-19.8786-52.1315-86.2299-88.0865
Pre-Tax Profit Margin-7.2734-6.791-66.6572-67.8665-99.067-99.3933
Net Profit Margin-6.8925-6.8321-66.685-67.8739-99.0492-99.407
Asset Turnover0.69631.1110.89131.12850.74960.5841
Inventory Turnover Ratio3.73993.42544.72682.35272.86182.6375
Receiveable Turnover6.06897.77735.22455.17497.5415.1832
Days Sales In Receivables60.143146.931569.863170.533248.402170.4197
ROE - Return On Equity-9.3862-12.6952-93.4001250.55911407.914-114.1016
Return On Tangible Equity-9.3862-12.6952-93.4001238.63091082.181-118.0254
ROA - Return On Assets-4.7992-7.5904-59.4351-76.5979-74.2464-58.0621
ROI - Return On Investment-6.0395-12.6952-93.4001-154.1008-114.2593-78.0846
Book Value Per Share5.87643.28272.2809-2.8805-1.905820.9777
Operating Cash Flow Per Share-0.31180.889111.4778.3610.30876.0547
Free Cash Flow Per Share-0.42720.617212.422110.275-0.61945.9548